A Trial of TBL12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study proposes to determine the clinical activity of this agent in patients with
asymptomatic multiple myeloma. It is believed that TBL12 will help delay the onset of active
multiple myeloma, with very few-if any- side effects.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health